Editorial Comment on: Degarelix: a Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dose-Finding Study in the Treatment of Prostate Cancer
Patrick J. BastianVolume:
54
Year:
2008
Language:
english
DOI:
10.1016/j.eururo.2008.04.066
File:
PDF, 75 KB
english, 2008